Targeting the isoprenoid pathway to abrogate progression of pulmonary fibrosis.
Osborn-Heaford HL, Murthy S, Gu L, Larson-Casey JL, Ryan AJ, Shi L, Glogauer M, Neighbors JD, Hohl R, Carter AB.
Osborn-Heaford HL, et al. Among authors: carter ab.
Free Radic Biol Med. 2015 Sep;86:47-56. doi: 10.1016/j.freeradbiomed.2015.04.031. Epub 2015 May 7.
Free Radic Biol Med. 2015.
PMID: 25958207
Free PMC article.